The largest database of trusted experimental protocols

Lipofectamine 3000

Manufactured by Merck Group
Sourced in United States

Lipofectamine 3000 is a cationic lipid-based transfection reagent developed by Merck Group. It is designed to facilitate the delivery of nucleic acids, such as plasmid DNA and RNA, into a variety of mammalian cell lines. The product provides efficient and robust transfection without the need for specialized equipment or extensive optimization.

Automatically generated - may contain errors

40 protocols using lipofectamine 3000

1

Transient Expression of mNtcp and hNTCP

Check if the same lab product or an alternative is used in the 5 most similar protocols
For transient expression of the transporter, plasmids encoding for mNtcp (Slc10a1) or hNTCP (SLC10A1) were generated, amplifying the coding sequence from commercially obtained mRNA (Amsbio) by PCR. The following primers were used:
SLC10A1_for: 5′-ATGGAGGCCCACAACGCGTCT-3′,
SLC10A1_rev 5′-CTAGGCTGTGCAAGGGGA-3′;
Slc10a1_for 5`-GTGTTCACTGGGTCGGAGGATG-‘3,
Slc10a1_rev1 5`-CAGGTCCAGAGCAAATACTCATAGGAG-‘3.
Subsequently the amplicons were ligated into pEF6-V5/HIS (Invitrogen), followed by sequence verification (Microsynth). The resulting plasmids Slc10a1-pEF6 and SLC10A1-pEF6 and Lipofectamine 3000 (Sigma-Aldrich) were used for transfection of human cell lines. A standard transfection protocol was developed as follows: Plasmid DNA and P3000 reagent were diluted in Opti-MEM (Sigma-Aldrich) and rapidly mixed with Lipofectamine 3000 diluted Opti-MEM using a DNA-to-Lipofectamine 3000 w/V ratio of 3. After 5 min incubation, the transfection mix was added to adhered cells at a plasmid DNA concentration of 1 μg/mL. Control cells were either transfected with empty pEF6 vector or treated with Opti-MEM alone.
+ Open protocol
+ Expand
2

Transfection of miR-3908 Mimics and Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transfection with mimics of miR-3908 was performed using Lipofectamine 3000 (Sigma, Palo Alto, CA, USA) based on the manufacturer’s protocol. The mimics of miR-3908 were as follows: sense 5’-AAGGGAAGAUGGUGACCACUU-3’ and antisense 5’-AAGUGGUCACCAUCUUCCCUU-3’. The inhibitors of miR-3908 were as follow: 5’-GUGGUCACCAUCUUCCCUU-3’. Moreover, the NC was as follows: sense 5’-ACGUGACACGUUCGGAGAAUU-3’ and antisense 5’-AAUUCUCCGAACGUGUCACGU-3’ which was not homologous with the human genome sequences. qRT-PCR was used to identify the dose effect of miR-3908.
+ Open protocol
+ Expand
3

MTAP Knockout and Rescue in HCT116 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HCT116 cells were transfected using Lipofectamine 3000 (Thermo Fisher Scientific) with pSpCas9(BB)-2A-Puro (PX459) V2.0 (Addgene plasmid # 62988; http://n2t.net/addgene:62988;RRID:Addgene_62988 was a gift from Feng Zhang (Broad Institute, Cambridge MA) which expresses both Cas9 and gRNA [NTC: AAAATAGCAGTAAACTCAAC, MTAP KO seq 1: GTTTTGCCCCAAAACGAGAG, MTAP KO seq 2: GCCTGGTAGTTGACCTTTGA]. Successfully transfected cells were selected with puromycin (Sigma) and grown as clonal colonies. Clones were selected based initially on MTA efflux measured by LCMS; clones with greatest MTA efflux were selected, MTAP knockout was then confirmed by western blot. MTAP-KO HCT116 cells were transfected with pCMV-Hygro-MTAP and pCMV-Hygro-Negative control vector (Sino Biological) using Lipofectamine 3000 and selected using hygromycin B (Sigma) and grown as clonal colonies. Clones were selected based initially on MTA efflux measured by LCMS; clones with low MTA efflux were selected, then MTAP re-expression was confirmed by western blot.
+ Open protocol
+ Expand
4

Generation of MA104-shRNA-NSP2 Cell Line

Check if the same lab product or an alternative is used in the 5 most similar protocols
MA104-shRNA-NSP2 cell line was generated using the PiggyBac system. Briefly, 105 MA104 cells were co-transfected with the plasmid pCMV-HyPBase encoding the hyperactive variant of PiggyBac transposase Yusa et al., 2011 (link); Li et al., 2013 (link); Hubstenberger et al., 2017 (link) along with the plasmid pPB[shRNA]-EGFP:T2A:Puro-U6 harbouring shRNA targeting RVA NSP2 gene using Lipofectamine 3000 (Sigma-Aldrich), following the manufacturer’s instructions. The cells were maintained in DMEM supplemented with 10% FBS for 3  days, and then the cells were subjected to selection in the presence of 5  μg/ml puromycin (Sigma-Aldrich) for 4  days, prior to further selection by FACS sorting for EGFP expression.
+ Open protocol
+ Expand
5

Knockout of BCL6 Gene in Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
LN18 or U87-MG at approximately 70% confluence were transfected with each of PZFN1 and PZFN2 CompoZr Knockout Zinc Finger Nuclease plasmids targeted to BCL6 (Sigma Aldrich, USA), using Lipofectamine® 3000. After both 24 hours and 72 hours, the medium was collected and the debris and detached cell fraction was pelleted by centrifugation, and the supernatant aspirated. The adherent cells were then harvested and pelleted by centrifugation, or combined with the non-adherent fraction before pelleting by centrifugation. Cell pellets were stored at -80° C. gDNA was extracted from ZFN transfected cell pellets using the Quick-gDNA MiniPrep kit (Zymo Research, USA) as per the manufacturers protocol. gDNA was quantified by fluorometry before PCR amplification of a 381 bp fragment of the BCL6 using Phusion® High-Fidelity DNA Polymerase, and BCL6 locus forward primer (5’-GAAGAGTTCCTCAACAGCCG-3’), and reverse primer (5’-TTCTGGGATTGTTTCCTTGG-3’), using the following parameters: 1 cycle of 98 °C, 30 s. 30 cycles of 98 °C, 10s; 57 °C, 30 s; 72°C, 10 s. Nuclease activity was detected by CEL1 endonuclease digestion of heteroduplex DNA using the Surveyor® Mutation Detection Kit (IDT, USA) using the manufacturers protocol.
+ Open protocol
+ Expand
6

Cellular effects of DnaJB1 overexpression

Check if the same lab product or an alternative is used in the 5 most similar protocols
BV2 and HEK293 cells were cultured in high-glucose Dulbecco’s modified Eagle's medium (Sigma-Aldrich) supplemented with 10% fetal bovine serum (Corning) at 37°C in a humidified 5% CO2 atmosphere. Plasmids pIRES2-2N4R-EGFP, pIRES2-2N4R-EGFP-P2A-DnaJB1, and pIRES2-2N4R-EGFP-P2A-DnaJB1-tua2 were purified by endotoxin-free plasmid extraction kit (Promega) and transfected transiently into BV2 cells with Lipofectamine 3000 (Sigma-Aldrich), following the manufacturer’s instructions. The next day, cells were treated with 0.5 mM MA (determined by CCK8 [GlpBio]) for 48 h and then harvested for further analysis.
+ Open protocol
+ Expand
7

Immunoprecipitation and Western Blotting

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells cultured in 100-mm-diameter dishes (Thermo Fisher) were transfected with indicated plasmids using Lipofectamine 3000, and 36 h later, the cells were lysed with lysis buffer (150 mM NaCl, 50 mM Tris-HCl [pH 7.4], 1% Nonidet P-40, 0.5% Triton X-100, 1 mM EDTA, 0.1% sodium deoxycholate, 1 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl fluoride, and a protease inhibitor cocktail [Sigma-Aldrich]) on ice for 30 min. The cell lysate supernatant was collected by centrifuging and then precleared by incubation with protein G/protein A agarose for 1 h at 4°C. The supernatant was incubated with indicated antibodies overnight at 4°C and precipitated with protein G agarose/protein A agarose for 30 min at room temperature. Then, the precipitated protein G agarose/protein A agarose was centrifuged at 2,000 × g for 10 s and washed three times with PBS. Finally, the bound proteins were eluted by boiling for 10 min in 2 × loading buffer, followed by SDS-PAGE and immunoblotting. Immunoreactive bands were visualized using enhanced chemiluminescence (ECL) reagents (Bio-Rad).
+ Open protocol
+ Expand
8

Overexpression of FOXC2 in H9c2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
We seeded H9c2 cells into six-well plates. When the cell growth density reached 30%, we used Lipofectamine 3000 reagent (Sigma-Aldrich, St. Louis, MO, USA) to transfect NC plasmid and FOXC2 overexpression plasmid into H9c2 cells. RT-PCR was used to detect the transfection efficiency.
+ Open protocol
+ Expand
9

DCLK1 Overexpression and Knockdown in Pancreatic and Colorectal Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
DCLK1 isoform 1 or vector control was expressed in AsPC-1 cells utilizing lentivirus as previously described [21 (link)]. Overexpression was confirmed by Western blot. Knockdown of DCLK1 was achieved via transfecting SW480 cells with 50 nM of DCLK1-specific siRNA (Santa Cruz Biotechnology; SC-456178) or scrambled siRNA confirmed not to target any human genes for 72 h using Lipofectamine 3000 (Sigma). Efficient knockdown was confirmed by Western blot.
+ Open protocol
+ Expand
10

Knockdown of SNHG3 and SNORA73 in Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
LNAs (Qiagen) were designed to target SNORA73 and the SNHG3 lncRNA, or GFP as a control. pGFP-C-shLENTI lentiviral shRNA constructs (Origene TR30023) were designed to target hamster SNHG3 lncRNA or GFP as a control. See Supplementary Table 2. For LNA knockdown experiments in NIH 3T3 cells, 4.0 × 104 cells were seeded per well in a 6-well dish and transfected the following day with 25 nM LNA using Lipofectamine 3000 (ThermoFisher L3000015). SNHG3 and SNORA73 expression and palmitate-induced cell death were analyzed 48 h following transfection. For LNA knockdown in CHO cells, 2.5 × 105 cells were plated in 6-cm dishes and transfected the next day with 25 nM LNA using Lipofectamine 3000. For LNA knockdown in primary human fibroblasts, 5.0 × 104 cells were plated in 6-well plates, or 1.5 × 105 cells were seeded in 6-cm dishes. Cells were transfected with 25 nM LNA the following day using Lipofectamine 3000. For shRNA transduction experiments, virus was harvested from HEK293T cells (ATCC CRL-3216) that were transfected using Lipofectamine 3000 with shRNA constructs and Mission helper plasmids (Sigma SHP001). 5.0 × 105 CHO cells were seeded in 6-cm dishes, grown for 24 h, and transduced with shSCR or shSNHG3 lentiviral particles. After expansion of the population, the top 20 percent of cells were flow-sorted and maintained as the transduced population.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!